These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 25635684

  • 1. The major birch pollen allergen Bet v 1 induces different responses in dendritic cells of birch pollen allergic and healthy individuals.
    Smole U, Radauer C, Lengger N, Svoboda M, Rigby N, Bublin M, Gaier S, Hoffmann-Sommergruber K, Jensen-Jarolim E, Mechtcheriakova D, Breiteneder H.
    PLoS One; 2015; 10(1):e0117904. PubMed ID: 25635684
    [Abstract] [Full Text] [Related]

  • 2. Differential T-cell responses and allergen uptake after exposure of dendritic cells to the birch pollen allergens Bet v 1.0101, Bet v 1.0401 and Bet v 1.1001.
    Smole U, Balazs N, Hoffmann-Sommergruber K, Radauer C, Hafner C, Wallner M, Ferreira F, Grössinger R, de Jong EC, Wagner S, Breiteneder H.
    Immunobiology; 2010 Nov; 215(11):903-9. PubMed ID: 20005001
    [Abstract] [Full Text] [Related]

  • 3. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen.
    Subbarayal B, Schiller D, Möbs C, de Jong NW, Ebner C, Reider N, Bartel D, Lidholm J, Pfützner W, Gerth van Wijk R, Vieths S, Bohle B.
    Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565
    [Abstract] [Full Text] [Related]

  • 4. Prevention of birch pollen-related food allergy by mucosal treatment with multi-allergen-chimers in mice.
    Hoflehner E, Hufnagl K, Schabussova I, Jasinska J, Hoffmann-Sommergruber K, Bohle B, Maizels RM, Wiedermann U.
    PLoS One; 2012 Nov; 7(6):e39409. PubMed ID: 22768077
    [Abstract] [Full Text] [Related]

  • 5. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies.
    Möbs C, Ipsen H, Mayer L, Slotosch C, Petersen A, Würtzen PA, Hertl M, Pfützner W.
    J Allergy Clin Immunol; 2012 Nov; 130(5):1108-1116.e6. PubMed ID: 23021882
    [Abstract] [Full Text] [Related]

  • 6. Human blood basophils do not act as antigen-presenting cells for the major birch pollen allergen Bet v 1.
    Kitzmüller C, Nagl B, Deifl S, Walterskirchen C, Jahn-Schmid B, Zlabinger GJ, Bohle B.
    Allergy; 2012 May; 67(5):593-600. PubMed ID: 22188598
    [Abstract] [Full Text] [Related]

  • 7. In vivo Induction of Functional Inhibitory IgG Antibodies by a Hypoallergenic Bet v 1 Variant.
    Aglas L, Bethanis A, Chrusciel P, Stolz F, Gruen M, Jaakkola UM, Jongejan L, Yatkin E, Van Ree R.
    Front Immunol; 2020 May; 11():2118. PubMed ID: 33013894
    [Abstract] [Full Text] [Related]

  • 8. A nonallergenic birch pollen allergy vaccine consisting of hepatitis PreS-fused Bet v 1 peptides focuses blocking IgG toward IgE epitopes and shifts immune responses to a tolerogenic and Th1 phenotype.
    Marth K, Breyer I, Focke-Tejkl M, Blatt K, Shamji MH, Layhadi J, Gieras A, Swoboda I, Zafred D, Keller W, Valent P, Durham SR, Valenta R.
    J Immunol; 2013 Apr 01; 190(7):3068-78. PubMed ID: 23440415
    [Abstract] [Full Text] [Related]

  • 9. Bet v 1 and its homologous food allergen Api g 1 stimulate dendritic cells from birch pollen-allergic individuals to induce different Th-cell polarization.
    Smole U, Wagner S, Balazs N, Radauer C, Bublin M, Allmaier G, Hoffmann-Sommergruber K, Breiteneder H.
    Allergy; 2010 Nov 01; 65(11):1388-96. PubMed ID: 20557297
    [Abstract] [Full Text] [Related]

  • 10. Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy.
    Geroldinger-Simic M, Kinaciyan T, Nagl B, Baumgartner-Durchschlag U, Huber H, Ebner C, Lidholm J, Bartel D, Vieths S, Jahn-Schmid B, Bohle B.
    J Allergy Clin Immunol; 2013 Jan 01; 131(1):94-102. PubMed ID: 22921871
    [Abstract] [Full Text] [Related]

  • 11. Mapping of conformational IgE epitopes with peptide-specific monoclonal antibodies reveals simultaneous binding of different IgE antibodies to a surface patch on the major birch pollen allergen, Bet v 1.
    Gieras A, Cejka P, Blatt K, Focke-Tejkl M, Linhart B, Flicker S, Stoecklinger A, Marth K, Drescher A, Thalhamer J, Valent P, Majdic O, Valenta R.
    J Immunol; 2011 May 01; 186(9):5333-44. PubMed ID: 21451110
    [Abstract] [Full Text] [Related]

  • 12. Bet v 1, the major birch pollen allergen, initiates sensitization to Api g 1, the major allergen in celery: evidence at the T cell level.
    Bohle B, Radakovics A, Jahn-Schmid B, Hoffmann-Sommergruber K, Fischer GF, Ebner C.
    Eur J Immunol; 2003 Dec 01; 33(12):3303-10. PubMed ID: 14635038
    [Abstract] [Full Text] [Related]

  • 13. A novel role for neutrophils in IgE-mediated allergy: Evidence for antigen presentation in late-phase reactions.
    Polak D, Hafner C, Briza P, Kitzmüller C, Elbe-Bürger A, Samadi N, Gschwandtner M, Pfützner W, Zlabinger GJ, Jahn-Schmid B, Bohle B.
    J Allergy Clin Immunol; 2019 Mar 01; 143(3):1143-1152.e4. PubMed ID: 29920351
    [Abstract] [Full Text] [Related]

  • 14. Differential T-helper cell polarization after allergen-specific stimulation of autologous dendritic cells in polysensitized allergic patients.
    Ashjaei K, Bublin M, Smole U, Lengger N, Hafner C, Breiteneder H, Wagner S, Hoffmann-Sommergruber K.
    Int Arch Allergy Immunol; 2015 Mar 01; 166(2):97-106. PubMed ID: 25792188
    [Abstract] [Full Text] [Related]

  • 15. Cor a 1-reactive T cells and IgE are predominantly cross-reactive to Bet v 1 in patients with birch pollen-associated food allergy to hazelnut.
    Hofmann C, Scheurer S, Rost K, Graulich E, Jamin A, Foetisch K, Saloga J, Vieths S, Steinbrink K, Adler HS.
    J Allergy Clin Immunol; 2013 May 01; 131(5):1384-92.e6. PubMed ID: 23246018
    [Abstract] [Full Text] [Related]

  • 16. Monoclonal IgE antibodies against birch pollen allergens: novel tools for biological characterization and standardization of allergens.
    Kaul S, Scheurer S, Danz N, Schicktanz S, Vieths S, Hoffmann A.
    J Allergy Clin Immunol; 2003 Jun 01; 111(6):1262-8. PubMed ID: 12789227
    [Abstract] [Full Text] [Related]

  • 17. The Clinical Impact of Bet v 6 in Birch Pollen-Sensitized Patients.
    Gellrich D, Eder K, San Nicoló M, Berghaus A, Gröger M.
    Int Arch Allergy Immunol; 2017 Jun 01; 173(1):34-43. PubMed ID: 28494455
    [Abstract] [Full Text] [Related]

  • 18. Molecular composition and biological activity of commercial birch pollen allergen extracts.
    Focke M, Marth K, Valenta R.
    Eur J Clin Invest; 2009 May 01; 39(5):429-36. PubMed ID: 19302561
    [Abstract] [Full Text] [Related]

  • 19. IL-10-modulated dendritic cells from birch pollen- and hazelnut-allergic patients facilitate Treg-mediated allergen-specific and cross-reactive tolerance.
    Heinl PV, Graulich E, Weigmann B, Wangorsch A, Ose R, Bellinghausen I, Khatri R, Raker VK, Scheurer S, Vieths S, Saloga J, Steinbrink K.
    Allergy; 2024 Oct 01; 79(10):2826-2839. PubMed ID: 39073174
    [Abstract] [Full Text] [Related]

  • 20. Different IgE reactivity profiles in birch pollen-sensitive patients from six European populations revealed by recombinant allergens: an imprint of local sensitization.
    Movérare R, Westritschnig K, Svensson M, Hayek B, Bende M, Pauli G, Sorva R, Haahtela T, Valenta R, Elfman L.
    Int Arch Allergy Immunol; 2002 Aug 01; 128(4):325-35. PubMed ID: 12218371
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.